Summary:
This vaccine belongs to a group of vaccines known as mRNA vaccines and is being developed for the prevention of shingles, caused by the varicella-zoster virus, the virus responsible for chickenpox and shingles.
Criteria:At minimum:
- Is an adult 50 years of age or older at the time of consent (Screening Visit).
- Is in good health, in the opinion of the Investigator, based on review of medical history and physical examination performed at Screening.
Qualified Participants May Receive:
Over the course of the trial, the maximum amount you would be paid is $2770.